This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignee: Netherlands Translational Research Center B.v.. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- DA Kerkdriel, NL (2019)
- Kerkdriel, NL (2020)
- Oss, NL (2021)
Company Filing History:
Years Active: 2019-2021
Title: Innovations of Antonius Maria Van Doornmalen
Introduction
Antonius Maria Van Doornmalen is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for various biological processes. With a total of three patents to his name, his work has the potential to impact the treatment of several diseases.
Latest Patents
One of his latest patents involves 3-hydroxy-imidazolidin-4-one compounds as inhibitors of indoleamine 2,3-dioxygenase. This invention relates to a compound of Formula (I), or pharmaceutically acceptable enantiomers, or salts thereof. The present invention also discusses the use of these compounds as selective inhibitors of indoleamine 2,3-dioxygenase. Furthermore, it highlights their potential application in the treatment or prevention of diseases such as cancer, infections, central nervous system disorders, and immune-related disorders, either as a single agent or in combination with other therapies.
Another significant patent focuses on inhibitors of tryptophan 2,3-dioxygenase. Similar to the previous invention, this one also relates to a compound of Formula (I), or pharmaceutically acceptable enantiomers, or salts thereof. The invention emphasizes the use of these compounds as selective inhibitors of tryptophan 2,3-dioxygenase, with applications in treating or preventing cancer and central nervous system diseases or disorders.
Career Highlights
Antonius Maria Van Doornmalen is associated with the Netherlands Translational Research Center B.V., where he continues to innovate and contribute to the field of research and development. His work is characterized by a strong focus on therapeutic applications that address critical health issues.
Collaborations
He has collaborated with notable colleagues such as Adrianus Petrus Antonius De Man and Joost Cornelis Marinus Uitdehaag, enhancing the scope and impact of his research endeavors.
Conclusion
Antonius Maria Van Doornmalen's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work holds promise for improving treatment options for various diseases, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile